News Daily News No More Niacin, Fibrate Combinations With Statins: FDA Michael O'Riordan April 19, 2016
News Daily News Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion Shelley Wood April 18, 2016
News Daily News La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada Shelley Wood April 18, 2016
News Daily News Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows Michael O'Riordan April 14, 2016
News Daily News Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early Michael O'Riordan April 14, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Daily News El USPSTF Refuerza las Recomendaciones en materia de Prevención Primaria al asegurar que la Aspirina Solo Debería de Emplearse en Sujetos de Riesgo Alto Michael O'Riordan April 12, 2016
News Conference News ACC 2016 Toker’s Paradox? Marijuana Users Face Lower Short-Term Risks After Acute MI, Study Hints Todd Neale April 11, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI Caitlin E. Cox April 03, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9 Michael O'Riordan April 02, 2016